Tag: Motley Fool

The Pure Hydrogen Corporation (ASX: PH2) share price is out of form on Friday.

In morning trade, the clean energy company’s shares are down 9% to 28 cents.

What’s going on with the Pure Hydrogen share price?

Investors have been selling down the Pure Hydrogen share price today despite the company’s capital reorganisation taking shape.

At the end of last month, the company ceased to be a foreign registered company and became an Australian registered company.

In light of this, a capital reorganisation was undertaken, which saw the company’s chess depository interests (CDIs) cancelled on Thursday night. The fully paid ordinary class shares that were underlying these CDIs have now been distributed on a 1:1 basis.

However, with the process ongoing, Pure Hydrogen’s shares will be trading on a deferred settlement basis for a period of time. This is why you may see the PH2DD ticker code trading today.

Normal trading under the PH2 ticker code is expected to commence on 8 August. After which, on 10 August, the settlement of on market trades that were conducted on a deferred settlement basis will finally take place.

What is Pure Hydrogen?

Pure Hydrogen is a clean energy company with a collection of hydrogen, gas and mobility businesses and a strategic interest in H2X Global.

The Company has five hydrogen projects under development and three gas projects. These include Windorah Gas Project in the Cooper Basin, Australia’s most prolific onshore producing petroleum basin, Project Venus CSG in the Surat Basin in Queensland, and the Serowe Project CSG in Botswana.

It also owns a 19.99% stake in the recently listed Botala Energy Ltd (ASX: BTE), which is a coal bed methane explorer.

The post What’s going on with the Pure Hydrogen share price on Friday? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Pure Hydrogen shares run-up 24% after addressing ASX questions
• ASX hydrogen shares announced some big news last month, so why did so many end June in the red?
• Down 60% in 2022, what’s happening to the Pure Hydrogen share price?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/eyo8tDq

Immutep Ltd (ASX: IMM) shares underperformed in FY22 as markets took a turn for the worse. Most of the previous year’s gains were erased.

However, the biotech company has caught a bid in July, as healthcare shares continue to strengthen in the new financial year.

The Immutep share price is flat today at 32.5 cents but it has gained 10% since the start of the month. Similarly, the S&P/ASX 200 Health Care Index (ASX: XHJ) is up 9% over the same period.

That is in stark contrast to June, when Immutep shares slumped by around 30%. They are now down 35% since this time last year.

What’s next for Immutep shares?

Immutep describes itself as a “biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases”.

After bouncing from lows of 29 cents on 30 June, Immutep shares have traded sideways and now rest at 32.5 cents apiece.

Earlier this month, the company announced it was granted a new patent (7074341) titled “AntiLAG-3 Antibodies” by the Japanese Patent Office.

The patent concerns the company’s drug candidate, IMP761. It covers all pharmaceutical formulas using IMP761 and “the use of the compositions in the treatment of T-cell mediated inflammatory and autoimmune diseases”.

“Immutep is well placed to make important contributions to this rapidly emerging field of immunotherapy — in both cancer and autoimmune diseases,” CEO Mark Voigt said.

The company also advised that its phase II TACTI-002 trial showed favourable results at readouts last month.

The study looked at combining Immutep’s lead drug candidate, efti, in combination with MSD’s pembrolizumab.

The trial met its primary objective, showing favourable anti-tumour activity. This data is now set to be presented at the 2022 IASLC 2022 World Conference on Lung Cancer, held on 6–9 August in Austria.

Meanwhile, Immutep shares are rated as a buy from 100% of the analysts covering the company, according to Refinitiv Eikon data.

From this list, the consensus price target is $1.18 per share, suggesting a mammoth 269% upside potential if these brokers are correct.

The post What’s the outlook for Immutep shares in FY23? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• What’s the outlook for ASX biotech shares in FY23?
• Why did the Immutep share price plummet 31% last month?
• Here’s how ASX healthcare shares performed in FY22
• Here’s how ASX 200 healthcare shares performed in June
• Own Immutep shares? Here are 3 takeaways from the company’s investor update

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/u2s6WdV

It has been a volatile year for some of the ASX’s leading growth shares. Since the start of 2022, many names known for quickly growing revenue have seen share price declines.

I wouldn’t say that every single thing that has fallen is an opportunity, but there are some that I believe have very promising futures, and the lower prices represent good buying.

Quite a few ASX growth shares have rebounded strongly over the past month. For example, the Zip Co Ltd (ASX: ZIP) share price is up 65% over the last month at the time of writing. But I’m not talking about Zip in this article.

I think the two ASX growth shares below have a promising and profitable future. Here’s why.

Temple & Webster Group Ltd (ASX: TPW)

Temple & Webster is a leading e-commerce business that sells a wide array of homewares and furniture.

It offers for sale more than 200,000 products from hundreds of suppliers. Those products are sent directly to customers by suppliers, which reduces the need to hold inventory, allowing for a more extensive product range.

Temple & Webster also has its own product range and recently launched The Build, a website to sell home improvement products.

The Temple & Webster share price is currently down by 64% in 2022, which I believe makes it attractively priced. It’s up 17% in the last month.

This ASX growth share grew revenue by 23% between 1 January 2022 to 30 April 2022, compared to the prior corresponding period. Revenue was up 116% compared to 2020.

The company is using its rapidly-growing revenue to invest in areas building ‘key strategic moats’ around the business. This includes data, personalisation, artificial intelligence, augmented reality and logistics.

It’s also pursuing further organic growth opportunities, such as its private label offering, and keeping an eye out for acquisitions.

Volpara Health Technologies Ltd (ASX: VHT)

Volpara describes itself as a global leader in the research and development of artificial intelligence for the early detection of breast cancer.

Its software provides clinicians feedback on breast density, compression, dose and quality, enabling them to offer patients personalised breast care and enhanced risk assessment.

The Volpara share price has fallen 38% since the start of 2022, but it’s up 46% in the last month.

Its FY22 result displayed a number of attractive statistics. Total revenue rose 32% to NZ$26.1 million and the gross profit margin was 91%. The market share continues to grow – in FY22, 35.5% of US women had a group product applied to their images and data (up from 32% in the prior year).

The ASX growth share has also signed important deals in the last few weeks. It has announced a new research and development collaboration with Microsoft to accelerate the creation of a product that uses mammograms to identify potential cardiovascular issues. Volpara said that breast arterial calcifications were shown to be associated with cardiovascular disease outcomes.

It has also signed a deal with RadNet Inc, which includes Volpara Analytics software and Volpara Risk Pathways software. Risk Pathways will be embedded into eRAD, RadNet’s electronic medical record system. The contract incorporates a volume-based model with potential upside.

I think ongoing revenue growth will help as the company benefits from operating leverage, and grows from the deals it has signed.

The post Why I think these 2 ASX growth shares could keep marching upwards appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 ASX All Ordinaries shares going great guns on Thursday
• Why is the Temple and Webster share price up 7% today?
• Temple & Webster share price jumps 11% after hitting recent lows
• Does the FY23 outlook make ASX retail shares look like bargains?
• Why are these 2 ASX ecommerce shares hitting two-year lows?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Microsoft, Temple & Webster Group Ltd, VOLPARA FPO NZ, and ZIPCOLTD FPO. The Motley Fool Australia has positions in and has recommended VOLPARA FPO NZ. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/PpNZQBR

The Brickworks Limited (ASX: BKW) share price is having a positive finish to the week.

At one stage today, the building products company’s shares were up 4% to $21.00.

The Brickworks share price has since pulled back but remains up 1% to $20.30 at the time of writing.

Why is the Brickworks share price rising?

Investors have been bidding the Brickworks share price higher today after the company announced the launch of the Brickworks Manufacturing Trust.

According to the release, it is a new 50.1% owned joint venture manufacturing property trust with Goodman Group (ASX: GMG) that will initially house a portfolio of 15 manufacturing plants with an asset value of $416 million.

These will be tenanted by the company’s Australian Building Products businesses, such as Austral Bricks, Bristile Roofing, Austral Masonry and Austral Precast, on long leases. In fact, the weighted average lease expiry (WALE) will initially be 16 years.

Brickworks will retain 50.1% ownership of the new trust, with the remaining 49.9% interest sold to Goodman.

Trading update

In addition to the Brickworks Manufacturing Trust announcement, the company provided an update on its performance in FY 2022.

Brickworks advised that it expects to report record Property earnings in FY 2022, with Property EBIT likely to be in excess of $620 million. This compares to Property EBIT of $253 million in FY 2021.

The company’s CEO, Lindsay Partridge, explained that this was driven by major developments and changes to account policies.

During the second half of the financial year, we have made strong progress on a number of major developments within the Industrial JV Trust. At Oakdale West, new facilities for Coles, Woolworths, Australia Post and Telstra are all approaching practical completion. In a change of accounting policy, and consistent with our JV partner Goodman, we now recognise developments within the Trust at fair market value, if they are approaching practical completion, at the end of each period.

In addition, management revealed that its Building Products EBIT operations in both Australia and North America are expected to be higher in FY 2022 compared to the prior year. Partridge said:

EBIT from our Australian Building Products business is expected to be in excess of 20% higher than the prior year, not including the additional profit from the sale of properties into the new Brickworks Manufacturing Trust.

[In] North America, we expect EBIT in financial year 2022 to be more than double the prior year, including the impact of a number of quarry sites sold during the second half.

The post Brickworks share price higher on record earnings, Goodman deal appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why has the Brickworks share price leapt 10% in a month?
• 2 excellent ASX 200 shares to buy right now according to experts
• Down 28% so far this year, could the Goodman share price be ready to take off?
• Why cheap hamburgers could give beginner ASX share investors food for thought
• 2 ASX shares in a sector ready for a massive comeback

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Brickworks. The Motley Fool Australia has positions in and has recommended Brickworks. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/4apoYe2

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened 

A strong bull run that’s lasted all week came to a screeching halt on Thursday as crypto values fell and pulled Coinbase Global (NASDAQ: COIN) down with them. Some of the move was simply trading volatility, while some was because of very real concerns about the health of the market. 

Shares of Coinbase dropped as much as 6.6% today and were down 2.9% at 3 p.m. ET. Solana (CRYPTO: SOL) fell as much as 10.1% in the past 24 hours and is currently down 1.8%, while Cardano (CRYPTO: ADA) fell as much as 7.3% and is currently down 4.1%. 

So what 

The biggest news out of crypto was Blockchain.com announcing it will cut staff by 25%. The company said it will close an office in Argentina, cancel expansion plans in other countries, and cut back institutional lending.

It hasn’t been widely reported, but Blockchain.com had lent $270 million to Three Arrows Capital, and when the company filed for bankruptcy, it exacerbated an already down market. 

Funds Blockchain.com raised earlier this year are expected to keep the company solvent for the foreseeable future, but there was a need to cut back expenses dramatically. With customers’ funds being frozen at some exchanges, it wouldn’t be surprising if the company also loses customers as a result. 

Another big story was an insider at Coinbase and two related people being charged with insider trading in relation to trades made ahead of tokens being listed on Coinbase. The U.S. Department of Justice made the announcement this morning, and Coinbase has been cooperating for months on the investigation. At the very least, this is a black eye for the company.

The broader crypto sell-off seems to be simply taking a breather from a relatively hot week of trading. Some cryptocurrencies are up over 50% in just a few weeks, and naturally there can be a pullback when that happens. 

Now what 

As fast as the crypto industry moves, we continue to see fallout from the Three Arrows Capital collapse, and Blockchain.com is the latest victim. This may ultimately be good news as companies eventually take fewer risks and focus on their core businesses. Coinbase said earlier this week that it wasn’t impacted significantly by recent bankruptcy filings and hasn’t taken any losses on loans. 

I would expect more volatility for tokens and crypto stocks, but the companies that survive are well positioned to generate tremendous value for shareholders. Coinbase is currently proving that a conservative business model with a long-term vision is better than taking risks no one in crypto fully understood. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why crypto and Coinbase dropped on Thursday appeared first on The Motley Fool Australia.

(function() { function setButtonColorDefaults(param, property, defaultValue) { if( !param || !param.includes(‘#’)) { var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0]; button.style[property] = defaultValue; } } setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’); setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’); setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’); })()

More reading

• Solana Foundation slapped with class action lawsuit alleging SOL is a security
• Does this crypto rally have legs?
• Shiba Inu, Dogecoin, Solana surge higher: Where are meme coins headed from here?
• Why Bitcoin, Ethereum, and Cardano are rocketing higher today
• What Coinbase is building during the crypto winter

Motley Foll contributor Travis Hoium has positions in Coinbase Global, Inc. and Solana. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Coinbase Global, Inc. and Solana. The Motley Fool Australia has positions in and has recommended Solana. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/nREgIBD

Experts are always on the lookout for ASX shares in the All Ordinaries Index (ASX: XAO) that could be attractively priced opportunities.

As ASX share prices and company updates constantly change, so too do brokers modify their recommendations. It largely depends on a company’s progress and if the share price is at a sizeable discount or premium to the broker’s estimated value of that business.

After some recent company announcements, brokers released their latest views on these two growing All Ords ASX shares.

Bubs Australia Ltd (ASX: BUB)

Bubs is an infant formula business that sells goat infant formula, cow milk formula, toddler snacks and adult goat milk products.

The broker Citi recently reiterated its buy rating on Bubs, with a price target of $0.77. That implies a possible rise of around 26% over the next 12 months.

Citi pointed to the company’s quarterly update, which showed progress in China and the United States markets.

In the three months to June 2022, China’s revenue increased by 523% year on year, contributing 64% of quarterly sales. Corporate daigou sales were up 1,201% year on year and cross-border e-commerce sales rose by 20%.

Bubs noted that the Alpha Group equity-linked strategic partnership and the China launch of the Bubs A2 product had proven “highly successful” and remained its most profitable channel.

In the US, the All Ords ASX share was one of the first infant formula manufacturers to apply for and receive FDA temporary approval. Within 24 days, the first air cargo shipment appeared on major US retailer shelves.

Bubs advised that around 540,000 tins had been delivered to more than 5,400 US stores, with additional shipments and retailers planned in the near term.

The company will invest money to accelerate expansion, build inventory to mitigate the current logistics environment, build its presence in the US and triple the capacity of its processing and canning facility.

Megaport Ltd (ASX: MP1)

Megaport is a tech company that enables digital infrastructure to move into the cloud.

Broker UBS likes the company’s longer-term future and rates Megaport as a buy. The broker has set a price target of $16, which implies the Megaport share price could rise by around 90% over the next 12 months.

In its quarterly update for the three months to June 2022, Megaport reported $1 million of ‘normalised’ earnings before interest, tax, depreciation and amortisation (EBITDA). This is an increase of 126% quarter on quarter. It also made $1.6 million in positive operating cash flow (up 125%).

The All Ords ASX share also reported that monthly recurring revenue (MRR) rose by 13% quarter on quarter to $10.7 million for June 2022. Customer numbers increased 4% quarter on quarter to 2,643. Total ports also rose 6% quarter on quarter to 9,545, and average revenue per port went up by 6.8% quarter on quarter to $1,120.

Megaport CEO Vincent English said about the company’s outlook:

Closing fiscal year 2022 with a solid fourth quarter performance across all operating metrics provides excellent momentum going into fiscal year 2023. We have aligned our business to reduce cash burn and have a clear runway to profitability with a proven business plan.

We have a strong cash position with more than $80 million available. With a record of successfully executing on our plans, we have a high degree of confidence in FY23 and will continue to stay out front as the leading global network as a service provider.

The post Do these 2 All Ords ASX shares offer a hefty upside? appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• 3 ASX All Ordinaries shares going great guns on Thursday
• RBA in the spotlight; and Westpac hikes fixed rates. Scott Phillips on Nine’s Late News
• Brokers says the Megaport share price can keep charging higher
• Why Iluka, JB Hi-Fi, Megaport, and Zip shares are racing higher
• 3 ASX tech shares rocketing by over 15% today

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended MEGAPORT FPO. The Motley Fool Australia has recommended BUBS AUST FPO and MEGAPORT FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/zjQLuXe

The Ioneer Ltd (ASX: INR) share price is taking off this morning on news the company has entered an offtake agreement with car manufacturing monolith, Ford.

The agreement will see the ASX-listed lithium developer supplying 7,000 tonnes of lithium each year for Ford’s electric vehicles (EVs).

At the time of writing, the Ioneer share price is 53.5 cents, 8.08% higher than its previous close.

Let’s take a closer look at today’s news from the All Ordinaries Index (ASX: XAO) lithium stock.

Ioneer signs offtake agreement with Ford

The Ioneer share price is surging after the company signed an offtake agreement for lithium from its Rhyolite Ridge Project.

The project is located in Nevada, US. It’s expected to start production in the second half of 2025.

The offtake agreement will see Ford’s battery-making joint venture BlueOvalSK snapping up around 34% of the project’s expected average annual lithium output for five years.

Another 34% of the project’s output has already been promised to cathode supplier EcoPro.

Ioneer managing director Bernard Rowe commented on the news driving the company’s share price today, saying:

Simply put, this strategic relationship means Nevada lithium for American cars, and it will lead to job creation across all levels of the electric vehicle supply chain. We look forward to continuing to work with Ford and its partners to help develop a secure and reliable end-to-end US EV industry.

Lisa Drake, Ford’s vice president of EV industrialisation, said the agreement will support localised production of battery cells and help deliver EVs to millions of customers.

Ford has also signed offtake agreements with ASX lithium stocks Lake Resources NL (ASX: LKE) and Liontown Resources Limited (ASX: LTR). The former will deliver Ford 25,000 tonnes of lithium annually while the latter will provide 150,000 dry metric tonnes of spodumene concentrate.

Ioneer share price snapshot

Today’s gains haven’t been enough to boost the Ioneer share price back into the longer-term green.

It’s currently 34% lower than it was at the start of 2022. Though, it is 35% higher than it was this time last year.

The post Ioneer share price leaps 8% on Ford supply agreement appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here’s how this ASX lithium stock performed on its US debut

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/Y4s6Xef

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

What happened

Cryptocurrencies took a breather this morning after a nice rally in recent days, as investors digest more macro news and as the electric car maker Tesla (NASDAQ: TSLA) announced that it had sold much of its Bitcoin (CRYPTO: BTC) holdings. 

Over the past 24 hours as of 9:45 a.m. ET, the price of Bitcoin had fallen more than 5%, the price of Ethereum (CRYPTO: ETH) had fallen more than 6%, and the price of the meme token Dogecoin (CRYPTO: DOGE) was down nearly 7%. 

So what

The European Central Bank (ECB) caught the market off guard this morning by announcing that it would hike its key benchmark interest rate by 50 basis points (0.5%). The ECB has kept rates negative since 2014, so the move is a big deal, but investors didn’t think the ECB would start with a half point. Riskier assets including cryptocurrencies have not fared well amid the rising interest rate environment this year, as rising interest rates make safer assets yield more, which then essentially demands more of riskier assets typically trading at larger valuations.

But another reason for crypto’s sell-off today could be due to the revelation that Tesla has sold 75% of its Bitcoin holdings, which is equivalent to $936 million. Tesla initially invested $1.5 billion in Bitcoin early in 2021.

On Tesla’s second-quarter earnings call yesterday, CEO Elon Musk attributed the sale of Bitcoin to uncertainty surrounding how COVID-19 lockdowns would play out in China, which had imposed months-long lockdowns in several major cities earlier this year.

“So it was important for us to maximize our cash position, given the uncertainty of the COVID lockdowns in China. We are certainly open to increasing our Bitcoin holdings in the future, so this should not be taken as some verdict on Bitcoin. It’s just that we were concerned about overall liquidity for the company, given COVID shutdowns in China,” said Musk.

“And we have not sold any of our Dogecoin,” Musk added.

Later in Tesla’s earnings call, Musk also essentially punted when asked by an analyst about how he views Bitcoin as a hedge against inflation, a widely debated topic, and as a long-term asset. 

“Cryptocurrency is a sideshow to the sideshow,” said Musk, adding that “cryptocurrency is not something we think about a lot” and “we’re neither here nor there on cryptocurrency.”

Now what

Musk’s explanation for selling Bitcoin seems somewhat reasonable, but there’s no doubt that the famous entrepreneur has the power to move crypto markets. After all, Tesla’s decision to purchase Bitcoin definitely helped move the token higher, and Musk played a huge role in driving up the price of Dogecoin last year with his support of the meme token on social media.

Despite the sale, I still do see strong long-term potential for Bitcoin and Ethereum, both of which I expect to be around and stay relevant, although they could definitely go lower in the near term.

Bitcoin is the pioneer of blockchain technology and cryptocurrencies and continues to gain more exposure in the mainstream financial system. Ethereum with its smart-contract technology has many real-world use cases, and the network should improve after a set of ongoing upgrades is completed.

Dogecoin was created as a joke and does not seem to have any real-world use case or technical advantage over other cryptocurrencies, which is why I have no interest in investing in the token. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

The post Why Bitcoin, Ethereum, and Dogecoin are falling today appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Tesla sells 75% of Bitcoin holdings. Here’s why Elon Musk is unloading
• Does this crypto rally have legs?
• Here’s why the Bitcoin and Dogecoin prices are rocketing
• Ethereum surges, but Ethereum classic up much more on merge anticipation
• These are the stocks making hay from the Bitcoin price upturn

Bram Berkowitz has positions in Bitcoin and Ethereum. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Bitcoin, Ethereum, and Tesla. The Motley Fool Australia owns and has recommended Bitcoin and Ethereum. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

from The Motley Fool Australia https://ift.tt/xMnz1e0

The Syrah Resources Ltd (ASX: SYR) share price is charging higher on Friday.

In morning trade, the graphite producer’s shares are up a sizeable 6% to $1.40.

This means the Syrah share price is now up almost 17% this week.

Why is the Syrah share price storming higher?

The catalyst for the rise in the Syrah share price today has been the announcement of an agreement with a major automaker.

According to the release, Syrah has entered into a non-binding memorandum of understanding (MOU) with Ford Motor Company and SK On.

This MOU will evaluate a strategic arrangement that includes natural graphite active anode material (AAM) supply to the BlueOval SK joint venture from Syrah’s vertically integrated Vidalia AAM facility in Louisiana, United States.

Syrah is developing the Vidalia operation as a vertically integrated natural graphite AAM supply alternative for US battery supply chains with construction of a 11.25ktpa AAM facility. It is expected to be completed in the June 2023 quarter and is aiming to commence production in the September 2023 quarter.

What is the BlueOval SK joint venture?

The BlueOval SK joint venture is developing large-scale battery manufacturing facilities in Tennessee and Kentucky in the United States. This is with the aim of supplying lithium-ion batteries for Ford’s electric vehicle programs, including for a future full-size electric vehicle pickup truck.

Under the MOU, Syrah, Ford and SK On will continue testing and qualifying Vidalia’s AAM. The parties will then use commercially reasonable efforts to finalise a binding offtake agreement no later than 31 December 2022.

This offtake agreement will be between Syrah and the BlueOval SK joint venture for AAM from an expanded production facility at Vidalia and with an offtake commencement date of no later than 2028.

The post Syrah share price charges higher on Ford agreement appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Why this ASX graphite share is a buy: fund manager

from The Motley Fool Australia https://ift.tt/MKQuJEo

ASX dividend shares can be a really effective way of boosting investment income.

Interest rates may be rising in Australia, but many dividend-paying businesses still offer higher dividend yields than what someone may be able to get from a savings account.

I like that businesses also have the ability to invest for growth and can grow their dividends as earnings and/or cash flow increase.

However, it’s important to remember that dividends (and distributions) are not guaranteed. There may be years that shareholder payouts do not grow. Payouts can be reduced, or cut entirely.

But, I think these two companies have compelling futures as far as income growth and distributions are concerned.

Rural Funds Group (ASX: RFF)

Rural Funds is my favourite real estate investment trust (REIT) because of its assets and targeted distribution growth.

It owns a portfolio of farms across different sectors including cattle, almonds, vineyards, macadamias and cropping (sugar and cotton).

This ASX dividend share aims to grow its distribution by 4% per annum.

It can do this because of three factors. First, rental indexation is built into its contracts with its high-quality tenants, which are linked to a fixed increase or CPI inflation. This helps rental income grow organically each year.

Next, it is regularly investing in its farms to improve the productivity for tenants, increasing that farm’s capital value and rental potential.

Finally, it occasionally makes an acquisition to grow its portfolio.

In FY23, Rural Funds has guided that it will pay a distribution of 12.2 cents per share (including franking credits). That translates into a forward distribution yield of 4.5%.

Centuria Industrial REIT (ASX: CIP)

This ASX dividend share is another REIT, but it’s focused on industrial commercial properties in high-demand areas where there is a limited supply.

The REIT’s fund manager, Jesse Curtis, recently described the optimistic case for ongoing rental growth:

The Australian industrial real estate market remains underpinned by low vacancy and record tenant demand, which drives strong rental growth across all markets. With an active management team and high-quality industrial portfolio, Centuria Industrial REIT continues to be a beneficiary of these favourable market conditions with positive leasing activity and rental growth supporting portfolio valuations.

The portfolio was recently externally valued as at 30 June 2022, leading to a 1.3% increase in the book values compared to December 2021.

At December 2021, it had a net tangible asset (NTA) per unit of $4.21. The current Centuria Industrial REIT share price of $3.04 is at a 28% discount to this, leaving a lot of margin of safety for if/when book valuations decrease. Keep in mind that the Centuria Industrial REIT’s share price has fallen by more than 20% over the last six months.

CMC Markets has an estimated distribution from the REIT of 16.5 cents per unit in FY23, translating into a forward distribution yield of 5.4%.

The post Why I think these 2 ASX dividend shares are ideal for income investors appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Here are top 2 ASX dividend shares with great yields
• Analysts name 2 ASX dividend shares to buy with 5%+ yields
• Analysts name 2 top ASX dividend shares with big yields to buy
• Best ASX shares to buy in July 2022
• This is the latest ASX 200 sector to be hit by downgrades

Motley Fool contributor Tristan Harrison has positions in RURALFUNDS STAPLED. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended RURALFUNDS STAPLED. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/hKkDic2